Biocodex secures rights to Batten-1 and TX01 in agreement worth up to €173 million THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex ...

Batten-1 is being prepared for a Phase III trial scheduled to commence in 2026. Credit: Stock-Asso / Shutterstock.com. THX Pharma (Theranexus) and Biocodex have entered a strategic licensing agreement ...

Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 ...

GENTILLY, France--(BUSINESS WIRE)--THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing agreement to advance ...

GENTILLY, France, February 10, 2026--(BUSINESS WIRE)--THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing ...

DALI is placing low-frequency performance centre stage at ISE 2026, announcing THX Dominus certification for its premium V-16 F subwoofer. Aimed at high-end home cinema installations and large-scale ...

The co-screenwriter and sound designer of George Lucas' debut feature spoke at the American Cinematheque about the dystopian sci-fi classic and its ongoing relevance in the age of Donald Trump.

Skullcandy, Hecate, Cleer Audio, Razer, Sunplus among first to deliver THX Spatial Audio with advanced features as a precursor to THX Spatial Audio+ features coming in 2026 Consumer Electronics Show ...

THX Pharma (Theranexus) and Exeltis have reached a pivotal milestone, setting the stage for the regulatory submission of TX01 for Gaucher and Niemann-Pick type C diseases Lyon, France – Madrid, Spain ...

With TX01 and Batten-1, THX Pharma is entering a new strategic phase focused on regulatory approval, early access, and international commercialization of its medicines. Lyon, France – September 29, ...